189 related articles for article (PubMed ID: 38683131)
21. Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2.
Dorsey JF; Cunnick JM; Mane SM; Wu J
Blood; 2002 Feb; 99(4):1388-97. PubMed ID: 11830491
[TBL] [Abstract][Full Text] [Related]
22. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
Huang HM; Liu JC
J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
[TBL] [Abstract][Full Text] [Related]
23. Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML.
Zhao L; Shan Y; Liu B; Li Y; Jia L
Cell Death Dis; 2017 May; 8(5):e2830. PubMed ID: 28542127
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition.
Jacquel A; Colosetti P; Grosso S; Belhacene N; Puissant A; Marchetti S; Breittmayer JP; Auberger P
Oncogene; 2007 Apr; 26(17):2445-58. PubMed ID: 17043649
[TBL] [Abstract][Full Text] [Related]
25. miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation.
Huang T; Fu Y; Wang S; Xu M; Yin X; Zhou M; Wang X; Chen C
Biomed Pharmacother; 2019 Nov; 119():109413. PubMed ID: 31518872
[TBL] [Abstract][Full Text] [Related]
26. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells.
Nichols GL; Raines MA; Vera JC; Lacomis L; Tempst P; Golde DW
Blood; 1994 Nov; 84(9):2912-8. PubMed ID: 7524758
[TBL] [Abstract][Full Text] [Related]
27. Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell line.
Eisbruch A; Blick M; Evinger-Hodges MJ; Beran M; Andersson B; Gutterman JU; Kurzrock R
Cancer; 1988 Sep; 62(6):1171-8. PubMed ID: 3044574
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL).
Park T; Koptyra M; Curran T
J Biol Chem; 2016 Dec; 291(51):26273-26290. PubMed ID: 27807028
[TBL] [Abstract][Full Text] [Related]
29. EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway.
Huang R; Liu H; Chen Y; He Y; Kang Q; Tu S; He Y; Zhou X; Wang L; Yang J; Wu A; Li Y
Oncol Rep; 2018 Jan; 39(1):119-128. PubMed ID: 29192326
[TBL] [Abstract][Full Text] [Related]
30. MASL1 induces erythroid differentiation in human erythropoietin-dependent CD34+ cells through the Raf/MEK/ERK pathway.
Kumkhaek C; Aerbajinai W; Liu W; Zhu J; Uchida N; Kurlander R; Hsieh MM; Tisdale JF; Rodgers GP
Blood; 2013 Apr; 121(16):3216-27. PubMed ID: 23327923
[TBL] [Abstract][Full Text] [Related]
31. Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.
Park T; Large N; Curran T
J Biol Chem; 2021; 296():100390. PubMed ID: 33561443
[TBL] [Abstract][Full Text] [Related]
32. MiR-218 Inhibits Erythroid Differentiation and Alters Iron Metabolism by Targeting ALAS2 in K562 Cells.
Li Y; Liu S; Sun H; Yang Y; Qi H; Ding N; Zheng J; Dong X; Qu H; Zhang Z; Fang X
Int J Mol Sci; 2015 Nov; 16(12):28156-68. PubMed ID: 26703568
[TBL] [Abstract][Full Text] [Related]
33. Nobiletin Promotes Megakaryocytic Differentiation through the MAPK/ERK-Dependent EGR1 Expression and Exerts Anti-Leukemic Effects in Human Chronic Myeloid Leukemia (CML) K562 Cells.
Yen JH; Lin CY; Chuang CH; Chin HK; Wu MJ; Chen PY
Cells; 2020 Apr; 9(4):. PubMed ID: 32260160
[TBL] [Abstract][Full Text] [Related]
34. BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.
Srutova K; Curik N; Burda P; Savvulidi F; Silvestri G; Trotta R; Klamova H; Pecherkova P; Sovova Z; Koblihova J; Stopka T; Perrotti D; Polakova KM
Haematologica; 2018 Dec; 103(12):2016-2025. PubMed ID: 30049824
[TBL] [Abstract][Full Text] [Related]
35. De-regulated STAT5A/miR-202-5p/USP15/Caspase-6 regulatory axis suppresses CML cell apoptosis and contributes to Imatinib resistance.
Nie ZY; Yao M; Yang Z; Yang L; Liu XJ; Yu J; Ma Y; Zhang N; Zhang XY; Liu MH; Jiang LL; Luo JM
J Exp Clin Cancer Res; 2020 Jan; 39(1):17. PubMed ID: 31952546
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of transglutaminase 2 accelerates the erythroid differentiation of human chronic myelogenous leukemia K562 cell line through PI3K/Akt signaling pathway.
Kang SK; Lee JY; Chung TW; Kim CH
FEBS Lett; 2004 Nov; 577(3):361-6. PubMed ID: 15556610
[TBL] [Abstract][Full Text] [Related]
37. Smenospongine, a spongean sesquiterpene aminoquinone, induces erythroid differentiation in K562 cells.
Aoki S; Kong D; Matsui K; Kobayashi M
Anticancer Drugs; 2004 Apr; 15(4):363-9. PubMed ID: 15057141
[TBL] [Abstract][Full Text] [Related]
38. The up-regulation of miR-199b-5p in erythroid differentiation is associated with GATA-1 and NF-E2.
Li Y; Bai H; Zhang Z; Li W; Dong L; Wei X; Ma Y; Zhang J; Yu J; Sun G; Wang F
Mol Cells; 2014 Mar; 37(3):213-9. PubMed ID: 24608802
[TBL] [Abstract][Full Text] [Related]
39. MicroRNAs are involved in erythroid differentiation control.
Yang GH; Wang F; Yu J; Wang XS; Yuan JY; Zhang JW
J Cell Biochem; 2009 Jun; 107(3):548-56. PubMed ID: 19350553
[TBL] [Abstract][Full Text] [Related]
40. Ferritin Heavy Subunit Silencing Blocks the Erythroid Commitment of K562 Cells via miR-150 up-Regulation and GATA-1 Repression.
Zolea F; Battaglia AM; Chiarella E; Malanga D; De Marco C; Bond HM; Morrone G; Costanzo F; Biamonte F
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
